Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| LAB | NASDAQ | Standard BioTools Inc. | $0.83 | -4.81% | 994K | $326.17M |
| DBVT | NASDAQ | DBV Technologies S.A. | $13.63 | -1.66% | 191K | $326.05M |
| AIRS | NASDAQ | AirSculpt Technologies, Inc. | $4.61 | -1.28% | 266K | $325.22M |
| CV | NASDAQ | CapsoVision, Inc. | $6.49 | -1.67% | 70K | $324.26M |
| KROS | NASDAQ | Keros Therapeutics, Inc. | $10.06 | -0.79% | 141K | $321.9M |
| PRE | NASDAQ | Prenetics Global Limited | $18.74 | -3.50% | 149K | $318.59M |
| PRENW | NASDAQ | Prenetics Global Limited | $0.01 | -31.85% | 1K | $318.59M |
| VNDA | NASDAQ | Vanda Pharmaceuticals Inc. | $5.18 | -3.36% | 769K | $311.5M |
| LYEL | NASDAQ | Lyell Immunopharma, Inc. | $12.63 | -1.17% | 91K | $309.49M |
| ZNTL | NASDAQ | Zentalis Pharmaceuticals, Inc. | $4.62 | -0.11% | 1.2M | $308.24M |
| IKT | NASDAQ | Inhibikase Therapeutics, Inc. | $2.11 | +4.98% | 2.2M | $307.64M |
| ORGO | NASDAQ | Organogenesis Holdings Inc. | $2.39 | -1.65% | 1.2M | $307.53M |
| XOMAO | NASDAQ | XOMA Corporation | $24.96 | -0.02% | 0 | $301.58M |
| XOMAP | NASDAQ | XOMA Royalty Corporation | $24.98 | 0.00% | 0 | $301.34M |
| AVR | NASDAQ | Anteris Technologies Global Corp. | $8.13 | -0.73% | 503K | $299.09M |
| CARL | NASDAQ | Carlsmed, Inc. | $10.80 | -1.82% | 36K | $293.6M |
| MASS | NASDAQ | 908 Devices Inc. | $7.35 | -0.81% | 349K | $292.93M |
| CLLS | NASDAQ | Cellectis S.A. | $2.84 | +2.53% | 24K | $285.18M |
| FHTX | NASDAQ | Foghorn Therapeutics Inc. | $5.95 | -1.00% | 122K | $284.76M |
| FATE | NASDAQ | Fate Therapeutics, Inc. | $2.52 | -2.33% | 1M | $280.91M |
| APLMW | NASDAQ | Apollomics, Inc. | $0.02 | -4.52% | 675 | $280.82M |
| AMRN | NASDAQ | Amarin Corporation plc | $15.02 | -1.02% | 55K | $280.25M |
| ELDN | NASDAQ | Eledon Pharmaceuticals, Inc. | $3.85 | -6.78% | 1.3M | $276.33M |
| NMRA | NASDAQ | Neumora Therapeutics, Inc. Common Stock | $1.49 | -4.49% | 666K | $276.07M |
| OABIW | NASDAQ | OmniAb, Inc. | $0.06 | -33.22% | 2 | $274.67M |
| OSUR | NASDAQ | OraSure Technologies, Inc. | $3.87 | -2.27% | 298K | $273.33M |
| ALXO | NASDAQ | ALX Oncology Holdings Inc. | $2.03 | +0.50% | 1M | $273.16M |
| BCYC | NASDAQ | Bicycle Therapeutics plc | $4.16 | -1.19% | 572K | $268.56M |
| SLGL | NASDAQ | Sol-Gel Technologies Ltd. | $81.96 | +2.17% | 25K | $267.93M |
| SGHT | NASDAQ | Sight Sciences, Inc. | $4.91 | +4.47% | 145K | $267.15M |
| TKNO | NASDAQ | Alpha Teknova, Inc. | $4.97 | -4.42% | 130K | $266.46M |
| PROF | NASDAQ | Profound Medical Corp. | $7.26 | +5.99% | 272K | $263.81M |
| TMCI | NASDAQ | Treace Medical Concepts, Inc. | $4.32 | -7.30% | 242K | $259.49M |
| NAGE | NASDAQ | Niagen Bioscience Inc | $3.28 | -3.53% | 463K | $255.66M |
| EDIT | NASDAQ | Editas Medicine, Inc. | $2.88 | -3.36% | 1.5M | $254.54M |
| VRXA | NASDAQ | Veraxa Biotech Holding AG | $2.11 | +3.43% | 175K | $254.53M |
| TTRX | NASDAQ | Turn Therapeutics Inc. | $8.54 | -9.92% | 100K | $254.39M |
| IRD | NASDAQ | Opus Genetics, Inc. | $3.08 | +5.48% | 1.1M | $254.3M |
| SY | NASDAQ | So-Young International Inc. | $1.93 | +0.52% | 90K | $253.24M |
| TENX | NASDAQ | Tenax Therapeutics, Inc. | $16.96 | -3.34% | 1.2M | $249.88M |
| AGEN | NASDAQ | Agenus Inc. | $6.19 | +11.93% | 1.2M | $249.02M |
| ARTV | NASDAQ | Artiva Biotherapeutics, Inc. | $10.03 | -0.99% | 568K | $247.91M |
| ALT | NASDAQ | Altimmune, Inc. | $2.77 | -2.46% | 1.9M | $244.47M |
| ALMR | NASDAQ | Alamar Biosciences, Inc. | $25.88 | -0.04% | 246K | $242.63M |
| OABI | NASDAQ | OmniAb, Inc. | $2.03 | -0.49% | 321K | $241.75M |
| MGNX | NASDAQ | MacroGenics, Inc. | $3.70 | -7.73% | 2.7M | $235.18M |
| SMTI | NASDAQ | Sanara MedTech Inc. | $25.56 | +0.24% | 50K | $234.23M |
| IVA | NASDAQ | Inventiva S.A. | $4.46 | -1.11% | 667K | $231.84M |
| RNAC | NASDAQ | Cartesian Therapeutics, Inc. | $7.88 | -0.51% | 143K | $231.53M |
| SGMT | NASDAQ | Sagimet Biosciences Inc. | $7.07 | +0.86% | 911K | $230.35M |